Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$448.4M
+3.8% from 2023
Prescriptions
695K
$645.04 per claim
Patients
167K
75,033 prescribers
Total spending, 2024
$448.6M
$2,680.80 per patient
Medicare prescription drug plans paid $448.4M for Stiolto Respimat in 2024, for 695,225 prescriptions and refills to 167,276 patients (up 3.8% from 2023). The average cost per claim was $645.04.
California had the highest Medicare cost for Stiolto Respimat in 2024: $36.6M for 55,145 claims, followed by Florida ($31.7M).
Singwu D Law, pulmonary disease in New York, NY, had the highest Medicare cost for Stiolto Respimat in 2024: 1,252 claims costing $622K.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Singwu D Law New York, NY | Pulmonary Disease | 1,252 | 193 | $622K |
| Nelson N Aldana Tampa, FL | Pulmonary Disease | 1,524 | 333 | $554K |
| Carlos N Montalvo Bonilla |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 64,052 | 602,264 | 142,766 | $387.0M |
| 2023 | 69,907 | 643,635 | 155,787 | $432.1M |
| 2024 | 75,033 | 695,225 | 167,276 | $448.4M |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Internal Medicine |
| 897 |
| 198 |
| $443K |
| Rosa I Roman Carlo Mayaguez, PR | Pulmonary Disease | 613 | 118 | $301K |
| Kenneth K Sha Flushing, NY | Pulmonary Disease | 546 | 94 | $290K |
| Sanjeevkumar A Patel Appleton, WI | Pulmonary Disease | 409 | 111 | $280K |
| Jiten D Patel Spokane, WA | Internal Medicine | 498 | 131 | $278K |
| Oscar Rivera Caguas, PR | Pulmonary Disease | 559 | 104 | $276K |
| Jackie R Pfeifer Marshfield, WI | Nurse Practitioner | 534 | 87 | $275K |
| Chitra Kandaswamy Fresno, CA | Pulmonary Disease | 511 | 186 | $275K |
| Glorimar Santos Fajardo, PR | Pulmonary Disease | 543 | 129 | $272K |
| Ernesto Mejia Morristown, TN | Pulmonary Disease | 481 | 95 | $267K |
| Jamie R Lujan Las Cruces, NM | Nurse Practitioner | 301 | 86 | $249K |
| Fiona F Meller Azrieli Halethorpe, MD | Internal Medicine | 285 | 105 | $248K |
| Scott C Parrish Appleton, WI | Critical Care (Intensivists) | 385 | 83 | $243K |
| Richard C Redman Olympia, WA | Pulmonary Disease | 365 | 79 | $234K |
| Cory J Hicks Albuquerque, NM | Pulmonary Disease | 345 | 71 | $232K |
| Nestor J Flores Guayama, PR | Pulmonary Disease | 469 | 102 | $232K |
| Jahaira L Serrano Dominguez Arecibo, PR | Pulmonary Disease | 449 | 71 | $221K |
| Samer Alkhuja East Stroudsburg, PA | Pulmonary Disease | 300 | 73 | $217K |
| Jason B Karp Lake Success, NY | Pulmonary Disease | 243 | 77 | $216K |
| Ladly Abraham Conway, AR | Pulmonary Disease | 373 | 81 | $211K |
| Eileen Hsu Mc Lean, VA | Pulmonary Disease | 277 | 82 | $206K |
| Shankar Kandaswamy Newnan, GA | Critical Care (Intensivists) | 291 | 56 | $202K |
| Zulmari Campos Santiago Cayey, PR | Pulmonary Disease | 409 | 65 | $201K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Boehringer Ing. | 695,441 | $448.6M |